Health

Results: 1609-1620 of 6447

PR Newswire associated0

Blue Earth Therapeutics Reports Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

PR Newswire associated0

Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results

PR Newswire associated0

Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

PR Newswire associated0

Tackling the Silent Epidemic: World Kidney Day 2025 Shines Light on Early Detection of Kidney Disease

Ping An Health Reports First Full-Year Profit in 2024

PR Newswire associated0

Telix Adds Lead-212 Isotope Production Capability

Business Wire logo

ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP

Business Wire logo

ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV

OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award

PR Newswire associated0

Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association

PR Newswire associated0

Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership